Expression and function of tumour necrosis factor-α-converting enzyme in the central nervous system

被引：22

作者：

Moro, MA ^{[1
]}

Hurtado, O ^{[1
]}

Cárdenas, A ^{[1
]}

Romera, C ^{[1
]}

Madrigal, JLM ^{[1
]}

Fernández-Tomé, P ^{[1
]}

Leza, JC ^{[1
]}

Lorenzo, P ^{[1
]}

Lizasoain, I ^{[1
]}

机构：

[1] Univ Complutense Madrid, Fac Med, Dept Farmacol, ES-28040 Madrid, Spain

来源：

NEUROSIGNALS | 2003年 / 12卷 / 02期

关键词：

metalloproteases; neuroinflammation; stroke; ischemic tolerance; neuroprotection;

D O I：

10.1159/000071814

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Tumour necrosis factor-alpha (TNF-alpha)-converting enzyme (TACE/ADAM17) is a membrane protein belonging to the ADAM (a disintegrin and a metalloprotease) family able to cleave various membrane proteins, including the transmembrane form of TNF-alpha at its physiological processing site. Being an ADAM, TACE may mediate not only proteolysis but also adhesive interactions; however, the role of the disintegrin domain of TACE has not been studied. In the central nervous system (CNS), little is known about the physiological role of TACE, but some important pathophysiological functions have been reported recently, with both neurotoxic and neuroprotective repercussions. This article discusses and reviews the main contributions to this field of investigation addressing the expression and function of TACE in the CNS. Copyright (C) 2003 S. Karger AG, Basel.

引用

页码：53 / 58

页数：6

共 50 条

[21] Regulation of tumor necrosis factor-α and tumor necrosis factor converting enzyme in human osteoarthritis
Amin, AR
OSTEOARTHRITIS AND CARTILAGE, 1999, 7 (04) : 392 - 394
[22] Tumor necrosis factor-α and virus expression in the central nervous system of cats infected with feline immunodeficiency virus
Poli, A
Pistello, M
Carli, MA
Abramo, F
Mancuso, G
Nicoletti, E
Bendinelli, M
JOURNAL OF NEUROVIROLOGY, 1999, 5 (05) : 465 - 473
[23] Tumor necrosis factor-α-converting enzyme is expressed in multiple sclerosis
Kieseier, BC
Seifert, T
Tourtellotte, WW
Hartung, HP
NEUROLOGY, 2001, 56 (08) : A294 - A294
[24] Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
Chey, Shin Yee
Kermode, Allan G.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2022, 8 (01)
[25] A continuous fluorimetric assay for tumor necrosis factor-α converting enzyme
Jin, GX
Huang, XY
Black, R
Wolfson, M
Rauch, C
McGregor, H
Ellestad, G
Cowling, R
ANALYTICAL BIOCHEMISTRY, 2002, 302 (02) : 269 - 275
[26] Heterocyclic inhibitors of tumor necrosis factor-α converting enzyme (TACE)
Levin, Jeremy I.
HETEROCYCLES, 2006, 70 : 691 - +
[27] Effects of Exogenous Tumour Necrosis Factor-α on the Secretory Function of the Bovine Reproductive Tract Depend on Tumour Necrosis Factor-α Concentrations
Skarzynski, D. J.
Piotrowska, K. K.
Bah, M. M.
Korzekwa, A.
Woclawek-Potocka, I.
Sawai, K.
Okuda, K.
REPRODUCTION IN DOMESTIC ANIMALS, 2009, 44 (03) : 371 - 379
[28] Tumor necrosis factor-α and tumor necrosis factor-α converting enzyme are expressed in the transition zone of abdominal aortic aneurysm
Satoh, H
Satoh, M
Nakajima, T
Ohira, A
Masuda, T
Maesawa, C
Hiramori, K
Nakamura, M
CIRCULATION, 1999, 100 (18) : 699 - 699
[29] Tumour necrosis factor-α as a tumour promoter
Szlosarek, P
Charles, KA
Balkwill, FR
EUROPEAN JOURNAL OF CANCER, 2006, 42 (06) : 745 - 750
[30] Specific sequence elements are required for the expression of functional tumor necrosis factor-α-converting enzyme (TACE)
Milla, ME
Leesnitzer, MA
Moss, ML
Clay, WC
Carter, HL
Miller, AB
Su, JL
Lambert, MH
Willard, DH
Sheeley, DM
Kost, TA
Burkhart, W
Moyer, M
Blackburn, RK
Pahel, GL
Mitchell, JL
Hoffmann, R
Becherer, JD
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) : 30563 - 30570

← 1 2 3 4 5 →